Is a Clinical Trial Right for You? A Patient's Decision Guide
A structured decision framework — when trials make sense, what to weigh, and a checklist to discuss with your doctor.
Read article →Guides to clinical trials — how to find them, what the phases mean, and what is recruiting now.
A structured decision framework — when trials make sense, what to weigh, and a checklist to discuss with your doctor.
Read article →A printable checklist organized by category — safety, eligibility, logistics, during the trial, and after.
Read article →Step-by-step timeline from first inquiry through screening, treatment, follow-up, and completion.
Read article →Compare the pros and cons of trial participation vs standard care, including honest discussion of placebo arms.
Read article →What inclusion and exclusion criteria mean, the most common types, and what to do if you're excluded.
Read article →Types of compensation by phase, what insurance covers, and hidden costs to consider before enrolling.
Read article →The enrollment gap — only 3% of cancer patients join trials despite 76% interest. What this means for patients.
Read article →The December 2025 FDA guidance on broadening eligibility criteria and what it means for patients previously excluded.
Read article →A step-by-step guide to finding recruiting clinical trials, understanding eligibility, and talking to your doctor about participation.
Read article →What happens in each phase of a clinical trial — from first-in-human safety testing to post-approval monitoring.
Read article →An overview of currently recruiting cancer clinical trials with sponsor analysis and condition breakdown.
Read article →Post-Leqembi era — next-gen amyloid, tau-targeting, and biomarker-based trials recruiting now.
Read article →The GLP-1 revolution, islet cell transplants, and recruiting trials for both Type 1 and Type 2 diabetes.
Read article →SGLT2 inhibitors, RNA therapies, and device trials — what's recruiting for heart failure, AFib, and more.
Read article →Psychedelic research, digital therapeutics, and treatment-resistant depression trials recruiting now.
Read article →CAR-T for autoimmune disease, next-gen JAK inhibitors, and bispecific antibodies in recruiting trials.
Read article →Gene therapy, orphan drug incentives, and how to search for trials when your condition affects few people.
Read article →